Staffing 360 Solutions Announces Closing of $5 Million Public Offering A Quirky Look at Staffing 360 Solutions’ Latest News Hey there, readers! Did you hear the latest news from Staffing 360 Solutions, Inc.? They recently announced the closing of a $5 million public offering. How exciting is that? It’s always interesting to see companies make…
Oh, Honda! Investor Alert! by Your Quirky Blogger Well, well, well, look who’s in hot water now! The folks over at Kaplan Fox & Kilsheimer LLP are stirring up trouble for Honda Motor Co., Ltd. If you’ve been living under a rock, let me fill you in: there’s a class action lawsuit brewing, and it’s…
Breaking News: Investor Alert for National Vision Holdings, Inc. Stay informed with Kaplan Fox & Kilsheimer LLP What’s Going On? Hey there, investors! Have you heard the latest news about National Vision Holdings, Inc.? Kaplan Fox & Kilsheimer LLP is currently looking into claims on behalf of investors of the optical retailer, National Vision. If…
Kraken discontinues crypto staking in US following a $30 million settlement with SEC The SEC’s Complaint According to SEC’s complaint, Kraken has offered and sold its crypto asset “staking services” since 2019, advertising annual investment returns of as much as 21%. SEC Chair Gary Gensler commented: Whether it’s through staking-as-a-service, lending, or other means, crypto…
Potbelly Corporation Announces Replacement of Short-Term Revolver with $25 Million Five-Year Term Loan New term loan provides Potbelly financial flexibility to support the Company through next phase of growth CHICAGO, Feb. 10, 2023 (GLOBE NEWSWIRE) — Potbelly Corporation (NASDAQ: PBPB) (“Potbelly” or the “Company”), the iconic neighborhood sandwich shop, today announced it closed on a…
VYNE Therapeutics Announces Reverse Stock Split Common stock expected to begin trading on split-adjusted basis on February 13, 2023 BRIDGEWATER, N.J., Feb. 10, 2023 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a biopharmaceutical company developing proprietary, innovative, and differentiated therapies for the treatment of immuno-inflammatory conditions, today announced that its…
Ayala Pharmaceuticals Reports Financial Results for the Fiscal Year Ended October 31, 2022 Management Commentary Upon announcing the financial results for the fiscal year ended October 31, 2022, Ayala Pharmaceuticals expressed their satisfaction with the successful merger that took place during this time. The company’s management team is optimistic about the future and the opportunities…
My Take on the New BOJ Governor Appointment What the Recent News Means for the Yen Bulls The report earlier says that the Japan government is set to appoint Kazuo Ueda as the next BOJ governor, after current deputy governor, Masayoshi Amamiya, firmly rejected their approach to succeed Kuroda. The reaction to me reads more…
